Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
SLS009
i
Other names:
SLS009, GFH009, GFH-009, GFH 009
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
GenFleet Therap, SELLAS Life Sciences
Drug class:
CDK9 inhibitor
Related drugs:
‹
DSP-2033 (8)
KB-0742 (8)
CYC065 (6)
VIP152 (5)
ME-522 (3)
TG02 (2)
BTX-A51 (1)
CDDD11-8 (1)
PRT2527 (1)
AZD4573 (1)
A-1592668 (0)
TP-1287 (0)
BAY 1143572 (0)
CYC202 (0)
DSP-2033 (8)
KB-0742 (8)
CYC065 (6)
VIP152 (5)
ME-522 (3)
TG02 (2)
BTX-A51 (1)
CDDD11-8 (1)
PRT2527 (1)
AZD4573 (1)
A-1592668 (0)
TP-1287 (0)
BAY 1143572 (0)
CYC202 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Peripheral T-cell Lymphoma
No biomarker
Peripheral T-cell Lymphoma
SLS009
Sensitive: B - Late Trials
SLS009
Sensitive
:
B
SLS009
Sensitive: B - Late Trials
SLS009
Sensitive
:
B
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login